Prognostic values of serum IP-10 and IL-17 in Patients with Pulmonary Tuberculosis
Objective: To identify patients at high risk of relapse after anti-tuberculosis (TB) therapy or with poor long-term outcomes.
Main Authors: | Yung-Che Chen, Chien-Hung Chin, Shih-Feng Liu, Chao-Chien Wu, Chia-Cheng Tsen, Yi-Hsi Wang, Tung-Ying Chao, Chien-Hao Lie, Chung-Jen Chen, Chin-Chou Wang, Meng-Chih Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.3233/DMA-2011-0808 |
Similar Items
-
Blood Absolute T Cell Counts may Predict 2-Month Treatment Response in Patients with Pulmonary Tuberculosis
by: Yung-Che Chen, et al.
Published: (2010-01-01) -
Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis, and natural killer cell counts
by: Tsen Chia-Cheng, et al.
Published: (2010-01-01) -
The role of IL-17 and Th17 cells in the pathogenesis of periodontitis
by: Cheng, Wan-Chien
Published: (2015) -
Effect of radiotherapy and chemotherapy on levels of serum S100B, IL-6, and IL-17 in patients with malignant glioma
by: Chao Xiang, et al.
Published: (2018-10-01) -
Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
by: Dan Wang, et al.
Published: (2019-08-01)